Shell Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Shell Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,545	Closed	-$1.08M	–	1537
2021 Q2	$1.08M	Sell	6,545 -1,209	-16%	-$202K	0.02%	532
2021 Q1	$1.19M	Buy	7,754 +1,759	+29%	+$239K	0.02%	478
2020 Q4	$752K	Hold	5,995	–	–	0.02%	600
2020 Q3	$608K	Hold	5,995	–	–	0.01%	597
2020 Q2	$583K	Sell	5,995 -76	-1%	-$7.07K	0.01%	591
2020 Q1	$504K	Sell	6,071 -92	-1%	-$8.97K	0.01%	664
2019 Q4	$685K	Sell	6,163 -143	-2%	-$14.7K	0.01%	727
2019 Q3	$626K	Buy	+6,306	New	+$626K	0.01%	777

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Shell Asset Management's PRAH Position: Q3 2021 in Review

Shell Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 6,545 shares — an estimated $1.08M sold.

Shell Asset Management first reported a position in PRAH in Q3 2019 and held it in 8 quarters. The position peaked at $1.19M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Shell Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Shell Asset Management sold 6,545 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.08M.
Shell Asset Management first reported a position in PRA Health Sciences, Inc. in Q3 2019 and held it in 8 quarters.
Shell Asset Management's PRA Health Sciences, Inc. position peaked at $1.19M in Q1 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Shell Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.